Hepatitis B News and Research

Latest Hepatitis B News and Research

Schools, pediatricians look to make up lost ground on non-covid vaccinations

Melissa Blatzer was determined to get her three children caught up on their routine immunizations on a recent Saturday morning at a walk-in clinic in this Denver suburb. It had been about a year since the kids' last shots, a delay Blatzer chalked up to the pandemic.

18 Nov 2021

Combination treatment improves overall survival for melanoma patients with brain metastases

Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.

11 Nov 2021

UK's health and social care providers required to ensure workers are fully vaccinated against COVID-19

Health and social care providers in England will be required to ensure workers are fully vaccinated against COVID-19, unless they are exempt, under plans announced by the Health and Social Care Secretary.

9 Nov 2021

The role of T follicular helper cells in the humoral immune response to SARS-CoV-2

The current analysis indicates that cTfh cells react to the spike antigen following vaccination are associated with anti-S protein neutralizing antibodies.

9 Nov 2021

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and MitoPower LLC were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism.

9 Nov 2021

Hemin as a potential therapy for COVID-19

The current study explores the antiviral activity of HO-1 induced by hemin against SARS-CoV-2 and attempts to describe the mechanism of its anti-viral action.

8 Nov 2021

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

A new study describes a new small molecule compound that has shown impressive safety, tolerability, and bioavailability against SARS-CoV-2.

7 Nov 2021

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Researchers from Texas A&M University inoculated MHV (SARS-CoV-2 surrogate) into a meat processing environmental biofilm and developed it on stainless steel (SS), PVC, and tiles at 7°C.

4 Nov 2021

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Cancer is the second leading cause of death in New York State after heart disease among adults and the second cause of death among children after injuries. And the number of people diagnosed with the disease increases every year.

2 Nov 2021

End-stage renal disease negatively impacts COVID-19 vaccine response

Researchers perform a systematic review of people with end-stage kidney disease receiving SARS-CoV-2 vaccines to assess their immunogenicity rates.

2 Nov 2021

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

The researchers investigated the neutralizing activity of turmeric root extract, curcumin-containing capsules, and pure curcumin against SARS-CoV-2.

1 Nov 2021

Study analyzes the financial burden of chronic hepatitis C on Ontario patients

Ontarians with chronic hepatitis C can lose up to 20 per cent of their overall income managing their condition, a new study has found.

1 Nov 2021

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

29 Oct 2021

Study focuses on the high hepatitis C rates in pregnant people

Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their babies.

29 Oct 2021

Third dose of Covid-19 vaccine benefits dialysis patients

In some patients, the immune system responds poorly to the second vaccination dose. This changes with the third shot.

28 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Study finds significant surge in liver transplantation for alcoholic hepatitis during the pandemic

Registrations for the national organ transplant waiting list related to alcoholic hepatitis as well as the number of deceased donor liver transplants for the inflammatory liver condition rose significantly during the pandemic, Michigan Medicine researchers found.

26 Oct 2021

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A new study examines the potential binding interaction of the beneficial components of Chaga mushroom with that of the SARS-CoV-2 RBD.

24 Oct 2021

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.

21 Oct 2021

Hepatitis B News and Research

Latest Hepatitis B News and Research

Schools, pediatricians look to make up lost ground on non-covid vaccinations

Combination treatment improves overall survival for melanoma patients with brain metastases

UK's health and social care providers required to ensure workers are fully vaccinated against COVID-19

The role of T follicular helper cells in the humoral immune response to SARS-CoV-2

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Hemin as a potential therapy for COVID-19

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

End-stage renal disease negatively impacts COVID-19 vaccine response

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

Study analyzes the financial burden of chronic hepatitis C on Ontario patients

New evidence that SARS-CoV-2 virus can infect the inner ear

Study focuses on the high hepatitis C rates in pregnant people

Third dose of Covid-19 vaccine benefits dialysis patients

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Study finds significant surge in liver transplantation for alcoholic hepatitis during the pandemic

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Hepatitis B News and Research

Latest Hepatitis B News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in